MedTrace Logo

Influence of of Cream With the Silver Fir Wood Extract (Belinal) on Skin

NCT02603029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-03-08

No results posted yet for this study

Summary

Objective of the study is to determine the influence of the cream with Silver fir wood (Abies alba) extract (Belinal) on the skin parameters and functions in comparison to the placebo cream. 10 healthy female subjects will use the test cream on one half and placebo cream on the other half of the face and of the gluteal part twice a day for 12 weeks. Various face skin parameters will be evaluated before the cream use (the baseline), after 6 and after 12 weeks of the cream use. To evaluate the photoprotective potential of Belinal the minimal erythema dose (MED) will be determined before (the baseline) and after 12 weeks of the cream use at the gluteal area.

Conditions

  • Wrinkles
  • Ageing
  • Photoprotection
  • Skin Care
  • Skin Cream

Interventions

OTHER

Placebo cream

Subjects will use placebo cream twice per day for 12 weeks on one half of the face and of the gluteal area.

OTHER

Belinal cream

Subjects will use Belinal cream twice per day for 12 weeks on the other half of the face and of the gluteal area.

Sponsors & Collaborators

  • Abies Labs d.o.o.

    collaborator INDUSTRY

  • VIST - Faculty of Applied Sciences

    lead OTHER

Principal Investigators

  • Janko Zmitek, PhD · VIST - Faculty of Applied Sciences

  • Katja Zmitek, PhD · VIST - Faculty of Applied Sciences

  • Nataša Tavčar, BSc · VIST - Faculty of Applied Sciences

  • Tina Pogačnik, BSc · VIST - Faculty of Applied Sciences

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02603029 on ClinicalTrials.gov